GlassScriptPhysician profile
David Michael Tadin
NPI 1508131814
$11,008.16
in general payments reported to CMS, 2019-2025
40 companies · $1,450 in 2025
The $1,450 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,517 · 2020: $657 · 2021: $736 · 2022: $3,212 · 2023: $2,131 · 2024: $1,305 · 2025: $1,450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,886.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,885.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,553.75 | 2022-2025 | Impella |
| Penumbra, INC. | $1,363.68 | 2022 | |
| Boston Scientific Corporation | $797.73 | 2019-2025 | Ranger, Sterling, Opticross 35 |
| Novartis Pharmaceuticals Corporation | $731.54 | 2019-2025 | |
| Cardiovascular Systems INC. | $650.48 | 2021-2022 | |
| Angiodynamics, INC. | $649.26 | 2023-2025 | Auryon Laser System 100-120 Vac, Alphavac |
| E.R. Squibb & Sons, L.L.C. | $647.27 | 2019-2025 | Camzyos, Eliquis |
| Shockwave Medical, INC | $558.70 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $437.29 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $334.01 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $329.55 | 2019-2023 | Xarelto |
| Medtronic, INC. | $319.66 | 2021-2025 | Hawkone, Symplicity G3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $286.17 | 2021-2023 | Jardiance |
| Philips North America LLC | $283.99 | 2019-2025 | Eagle Eye |
| Medtronic Vascular, INC. | $232.35 | 2020 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $182.79 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Edwards Lifesciences Corporation | $178.74 | 2019-2024 | |
| Csl Behring | $169.96 | 2019 | |
| Inari Medical, INC. | $163.05 | 2019 | |
| Silk Road Medical, INC. | $149.79 | 2022 | |
| Surmodics, INC. | $145.36 | 2022 | |
| Amgen INC. | $123.61 | 2019-2022 | |
| Abbott Laboratories | $116.51 | 2020-2025 | Diamondback Peripheral |
| Alnylam Pharmaceuticals INC. | $104.77 | 2023-2024 | Onpattro |
| Atricure, INC. | $94.88 | 2024-2025 | Synergy Ablation System |
| Merck Sharp & Dohme LLC | $82.01 | 2022-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $42.07 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $39.51 | 2025 | Evkeeza |
| Cardiva Medical, INC. | $37.85 | 2020-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Impulse Dynamics (USA) INC. | $29.47 | 2023 | Optimizer |
| Cvrx, INC. | $24.59 | 2024 | Barostim Neo System |
| Endologix LLC | $23.76 | 2025 | Endocross Device, Torus Stent Graft System |
| Kiniksa Pharmaceuticals International, Plc | $22.23 | 2024 | Arcalyst |
| Astellas Pharma US INC | $20.77 | 2019 | |
| Arbor Pharmaceuticals, INC. | $16.00 | 2019 | |
| Scpharmaceuticals INC. | $15.83 | 2025 | |
| Mannkind Corporation | $15.83 | 2025 | |
| Kestra Medical Technology Services, INC. | $15.81 | 2025 | Assure Wcd |
| Cordis US Corp. | $12.84 | 2023 | Saber |
| Asahi Intecc USA, INC. | $4.70 | 2024 | Peripheral Vascular |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Tadin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.